Image for Defining optimal immunotherapies for type 1 diabetes

Defining optimal immunotherapies for type 1 diabetes - v. 292

Part of the Novartis Foundation Symposium series
See all formats and editions

  • This book is a comprehensive and up-to-date account of where we stand in immunological strategies for preventing or treating type 1 diabetes (T1D).
  • Brings together contributions from the leaders in the arena of clinical immunotherapy, not limited to the diabetes field exclusively, in order to delineate a road-map that would lead to future clinical trials.
  • The book integrates information from human and animal studies.
  • The book considers T1D within the broader context of autoimmune disease.
  • The format contains several discussions, which address specific questions and provides guidelines for future strategies and solutions for discovering a cure.

Read More
Special order line: only available to educational & business accounts. Sign In
£157.95
Product Details
Wiley-Blackwell
0470697415 / 9780470697412
eBook (Adobe Pdf)
31/07/2008
England
English
206 pages
152. x 229. mm, 482 grams
Copy: 40%; print: 40%